Screening

  • Applied at the population level among asymptomatic individuals.
  • Screening should only be done if there are effective interventions among presymptomatic individuals. Else it may be worth waiting for symptoms.
  • An individual who does not actually have the disease but is predicted to have it will be enrolled into the healthcare system unnecessarily.
  • Disease prevalence should be expected to be much lower than in diagnostic settings - remember issues with PPV from Demonstration 1.
  • If screening has any side effects, than many individuals may be exposed to them.

Lead-time bias

  • Screening leads to early detection - early detection does not have any benefit.
  • Two patients die at the same time, but one was screened and cancer detected earlier.
  • The first individual is followed for longer.
  • Lead time bias: when length of follow-up makes you conclude that screening is useful: "Individuals lived longer due to screening".
  • Lead time bias: when you attribute benefit to simply observing people.

Length-time bias

  • Same number of fast and slow growing tumors over a period of time.
  • By chance, screening will find more slow growing tumors.
  • People with fast growing cancers will be diagnosed once symptoms are detected (or postmortem).
  • Length time bias: concluding that screening has an effect on cancer progress and risk of death when in fact slower growing cancers are oversampled by screening.

No gold standard

  • Predicitive assessments requires us to know the true value (Y+ or Y-).
  • If no gold standard exists which is efficient in classifying individuals then this adds further uncertainty to our estimates.

Missing data and selection bias

  • Predictions based on data for which there is systematic missingness - findings are biased.
  • Cannot generalise as easily, since datapoints collected are not from a random sample.
  • If we continuously screen, but the screening oversamples individuals with high risk, then we create a selection bias and PPV may be inflated.

Measurement bias

  • Even with a perfectly random sample from the correct population we may still be measuring the wrong thing.
  • Different measurement methods results in different Y+ and Y- classifications, biasing the estimate of prevalence.
  • Not always a problem (!) - The link between cancer and smoking is not dependent on the person reporting smoking 20 or 25 cigarettes per day.
  • Smoking cessation interventions targeting "smokers" may be helpful regardless of the exact number of cigarettes smoked.